Cargando…
Inhibiting influenza's immunopathology
Although a host of companies are pursuing sphingosine 1-phosphate as a target in cancer and autoimmune diseases, researchers at Scripps may have found new therapeutic real estate for S1P's receptor: lowering cytokine-related pulmonary tissue damage in influenza.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149082/ http://dx.doi.org/10.1038/scibx.2009.169 |